文献速递冠心病血脂与心血管预防

入院前他汀治疗与STEMI患者到院时循环崩溃的关联

Pre-admission statins and circulatory collapse at hospital arrival in ST-segment elevation myocardial infarction
RSS 订阅 · Open Heart

这项单中心回顾性研究纳入551例接受直接PCI的STEMI患者,发现入院前连续使用他汀≥30天者到院时循环崩溃发生率低于未使用者(7.5% vs 16.6%,p=0.005),多变量校正后OR为0.23(95%CI 0.10–0.50,p<0.001),但30天死亡率无显著差异。

要点

  • 入院前他汀治疗与STEMI到院时循环崩溃风险降低独立相关(校正OR 0.23)。
  • 循环崩溃总体发生率为14.0%,他汀组7.5%低于非他汀组16.6%。
  • 30天死亡率未因入院前他汀治疗状态而显著不同。

核心结论

  • 入院前他汀治疗与接受直接PCI的STEMI患者到院时循环崩溃风险降低相关,提示慢性他汀治疗可能关联较轻的早期血流动力学表型,但不能排除残余混杂。

研究设计与样本

  • 回顾性单中心研究,纳入551例接受直接PCI的连续STEMI患者。
  • 入院前他汀治疗定义为入院前连续使用他汀≥30天。
  • 主要结局为到院时循环崩溃,采用直接PCI前晚期血流动力学受损的操作性定义。
  • 采用多变量逻辑回归及倾向评分校正、逆概率治疗加权等敏感性分析。

主要发现

  • 77例(14.0%)发生循环崩溃,他汀组发生率7.5%低于非他汀组16.6%(p=0.005)。
  • 主要多变量模型中,入院前他汀治疗与循环崩溃风险降低相关(校正OR 0.23;95%CI 0.10至0.50;p<0.001)。
  • 敏感性分析结果一致,包括排除基于乳酸分类而无PCI前心肺复苏或药物/机械循环支持者、倾向评分校正、逆概率治疗加权及额外校正背景预防药物。
  • 30天死亡率根据入院前他汀治疗状态无显著差异。

临床怎么用

  • 对于STEMI患者,入院前长期他汀使用史可能提示到院时血流动力学崩溃风险较低。
  • 该关联不应改变基于指南的他汀一级和二级预防策略。

局限性

  • 回顾性单中心设计,不能排除残余混杂。
  • 入院前他汀治疗定义依赖连续使用≥30天,可能存在错分。
  • 循环崩溃采用操作性定义,非统一标准。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background Circulatory collapse at hospital arrival represents one of the most severe clinical presentations of ST-segment elevation myocardial infarction (STEMI) and is associated with poor prognosis. Statins exert pleiotropic effects beyond lipid-lowering, including anti-inflammatory, endothelial, microvascular and plaque-stabilising actions which may influence early clinical severity in myocardial infarction. We investigated the association between pre-admission statin therapy and circulatory collapse at hospital arrival in patients with STEMI undergoing primary percutaneous coronary intervention (PCI). Methods This retrospective single-centre study included 551 consecutive patients with STEMI undergoing primary PCI. Pre-admission statin therapy was defined as continuous statin use for ≥30 days before admission. The primary outcome was circulatory collapse at hospital arrival, defined using an operational definition of advanced haemodynamic compromise before primary PCI. Multivariable logistic regression and sensitivity analyses including propensity score adjustment and inverse probability of treatment weighting were performed. Results Circulatory collapse occurred in 77 patients (14.0%) and was less frequent among patients receiving statins than among those not receiving statins (7.5% vs 16.6%, p=0.005). In the primary multivariable model, pre-admission statin therapy was associated with a lower risk of circulatory collapse (adjusted OR 0.23; 95% CI 0.10 to 0.50; p<0.001). This association remained consistent across sensitivity analyses, including exclusion of lactate-based classification without pre-PCI cardiopulmonary arrest or pharmacological/mechanical circulatory support, propensity score adjustment, inverse probability of treatment weighting and additional adjustment for background preventive medications. 30-day mortality did not differ significantly according to pre-admission statin therapy status. Conclusions Pre-admission statin therapy was associated with a lower risk of circulatory collapse at hospital arrival in patients with STEMI undergoing primary PCI. These findings suggest that chronic statin therapy may be associated with a less severe early haemodynamic phenotype at STEMI presentation, although residual confounding cannot be excluded.

来源:Open Heart,查看原文。版权归原作者所有。

引用

  1. Open Heart:Pre-admission statins and circulatory collapse at hospital arrival in ST-segment elevation myocardial infarction

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。